Table 3 Geographical distribution of seroprevalence to CVBD agents among apparently healthy dogs

Northwestern

177

62 (35.03)^**

22 (12.43)^**

0 (0)

10 (5.65)

55 (31.07)^**

21 (11.86)^**

[28.2–41.8]

[7.9–17.5]

[0.0–0.0]

[2.8–9.0]

[24.7–37.9]

[7.3–16.9]

Northeastern

223

48 (21.52)

6 (2.69)^*

0 (0)

13 (5.83)^*

33 (14.79)

4 (1.79)

[16.6–26.9]

[0.9–4.9]

[0.0–0.0]

[3.1–9.0]

[10.3–19.4]

[0.4–3.6]

Northcentral

107

0 (0)^**

0 (0)^*

0 (0)

0 (0)^*

0 (0)^**

0 (0)^*

[0.0–0.0]

[0.0–0.0]

[0.0–0.0]

[0.0–0.0]

[0.0–0.0]

[0.0–0.0]

Western

57

19 (33.33)

4 (7.02)

0 (0)

2 (3.51)

17 (29.82)

4 (7.02)

[21.1–45.6]

[1.8–14.0]

[0.0–0.0]

[0.0–8.8]

[17.5–42.1]

[1.8–14.0]

Eastern

131

26 (19.85)

7 (5.34)

0 (0)

5 (3.82)

17 (12.98)

2 (1.53)

[13.0–27.5]

[1.5–9.2]

[0.0–0.0]

[0.8–7.6]

[7.6–19.1]

[0.0–3.8]

Southcentral

46

5 (10.87)^*

2 (4.35)

0 (0)

0 (0)

4 (8.69)

1 (2.17)

[2.2–20.3]

[0.0–10.9]

[0.0–0.0]

[0.0–0.0]

[2.2–17.4]

[0.0–6.5]

Southwestern

86

34 (39.53)^*

5 (5.81)

0 (0)

0 (0)

32 (37.21)^**

3 (3.49)

[29.1–50.0]

[1.2–11.6]

[0.0–0.0]

[0.0–0.0]

[27.5–47.7]

[0.0–8.1]

South-eastern

116

33 (28.45)

12 (10.35)

0 (0)

1 (0.86)

24 (20.69)

4 (3.45)

[20.7–37.1]

[5.2–16.4]

[0.0–0.0]

[0.0–2.6]

[13.8–28.4]

[0.9–6.9]

Mexican

states

943

227 (24.07)

58 (6.15)

0 (0)

31 (3.29)

182 (19.30)

39 (4.13)

[21.3–26.8]

[4.7–7.6]

[0.0–0.0]

[2.2–4.5]

[16.8–21.8]

[3.0–5.5]